Analysts expect Opus Genetics, Inc. to report revenue of 1.59 M for Q3 26, against a range of 1.44 M to 1.73 M. The most recent reported quarter, Q2 26, came in at 755,000.00, a 70.7% miss against the 2.57 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 3.87 M | 4.30 M | 4.37 M | 2.88 M | 3.08 M | 3.87 M | 2.16 M | 755,000.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 2.41 M | 3.75 M | 3.43 M | 4.23 M | 3.23 M | 3.16 M | 3.30 M | 2.67 M | 1.73 M | 7.57 M | 1.73 M | 1.67 M | 2.01 M | 6.49 M | 6.25 M | 5.34 M | ||||||||||
| Low Estimate | 1.98 M | 3.50 M | 2.93 M | 3.67 M | 2.77 M | 2.80 M | 2.81 M | 2.47 M | 1.44 M | 6.69 M | 1.55 M | 1.52 M | 1.85 M | 6.01 M | 5.65 M | 4.89 M | ||||||||||
| Consensus Estimate | 2.20 M | 3.63 M | 3.18 M | 3.95 M | 3.00 M | 2.98 M | 3.06 M | 2.57 M | 1.59 M | 7.13 M | 1.64 M | 1.59 M | 1.93 M | 6.25 M | 5.95 M | 5.11 M |
Analysts expect Opus Genetics, Inc. to report earnings per share of -0.15 for Q3 26, against a range of -0.16 to -0.14. The most recent reported quarter, Q2 26, came in at -0.14, a 12.5% beat against the -0.16 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.29 | -1.27 | -0.24 | -0.12 | -0.25 | -0.19 | -0.75 | -0.14 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.25 | -0.23 | -0.25 | -0.20 | -0.11 | -0.09 | -0.11 | -0.15 | -0.14 | -0.08 | -0.15 | -0.17 | -0.12 | -0.07 | -0.07 | -0.03 | ||||||||||
| Low Estimate | -0.27 | -0.27 | -0.29 | -0.22 | -0.13 | -0.11 | -0.13 | -0.17 | -0.16 | -0.10 | -0.17 | -0.19 | -0.14 | -0.07 | -0.09 | -0.03 | ||||||||||
| Consensus Estimate | -0.26 | -0.25 | -0.27 | -0.21 | -0.12 | -0.10 | -0.12 | -0.16 | -0.15 | -0.09 | -0.16 | -0.18 | -0.13 | -0.07 | -0.08 | -0.03 |
Pull Wall Street consensus for Opus Genetics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=IRD&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "IRD", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=IRD&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();